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ABSTRACT
The P body protein LSm1 stimulates translation and
replication of hepatitis C virus (HCV). As the liver-
specific microRNA-122 (miR-122) is required for
HCV replication and is associated with P bodies,
we investigated whether regulation of HCV by
LSm1 involves miR-122. Here, we demonstrate that
LSm1 contributes to activation of HCV internal
ribosome entry site (IRES)-driven translation by
miR-122. This role for LSm1 is specialized for miR-
122 translation activation, as LSm1 depletion does
not affect the repressive function of miR-122 at
30 untranslated region (UTR) sites, or miR-122–
mediated cleavage at a perfectly complementary
site. We find that LSm1 does not influence recruit-
ment of the microRNA (miRNA)-induced silencing
complex to the HCV 50UTR, implying that it regulates
miR-122 function subsequent to target binding. In
contrast to the interplay between miR-122 and
LSm1 in translation, we find that LSm1 is not
required for miR-122 to stimulate HCV replication,
suggesting that miR-122 regulation of HCV transla-
tion and replication have different requirements. For
the first time, we have identified a protein factor that
specifically contributes to activation of HCV IRES-
driven translation by miR-122, but not to other
activities of the miRNA. Our results enhance under-
standing of the mechanisms by which miR-122 and
LSm1 regulate HCV.
INTRODUCTION
Hepatitis C virus (HCV) is a major global cause of disease,
with 2–3% of the population infected. The virus causes
chronic liver infections that may progress to cirrhosis
and hepatocellular carcinoma. The current drug regime
is poorly tolerated and frequently ineffective, and there
is an urgent need for better understanding of HCV
biology that may lead to novel therapeutic strategies (1).
HCV is a positive sense single-stranded RNA virus of the
Flaviviridae family. The HCV genome is 9.6 kb in length,
with a single open reading frame encoding structural
(core, E1, E2 and p7) and nonstructural (NS2, NS3,
NS4A, NS4B, NS5A and NS5B) proteins ﬂanked by
highly structured 50 and 30 UTRs (2). Both UTRs are
required for viral RNA replication, while the 50 UTR
contains an internal ribosome entry site (IRES) that
directly recruits the 40S ribosomal subunit and eukaryotic
initiation factor 3 to initiate cap-independent translation
of the viral polyprotein. In the cytoplasm, the viral
RNA ﬁrst serves as a template for translation before
replication takes place in association with endoplasmic
reticulum–derived membranes, with the viral NS5B
RNA-dependent RNA polymerase mediating synthesis
of new and+strand HCV RNA.
The highly expressed liver-speciﬁc microRNA-122
(miR-122) is essential for HCV replication and is a
promising antiviral target (3,4). Excitingly, an oligo-
nucleotide miR-122 inhibitor, miravirsen, recently
completed phase 2a clinical trials in HCV-infected
patients. The drug resulted in prolonged dose-dependent
reduction in viral RNA with minimal adverse effects and
without evidence of viral resistance (5), emphasizing the
clinical importance of HCV regulation by miR-122 and
the need for better understanding of its mechanism.
MicroRNAs (miRNAs) are small (21–23 nt) noncoding
RNA molecules that canonically function by binding to
partially complementary sites in the 30UTR of mRNA
targets, leading to translational repression and mRNA
degradation (6). In contrast, miR-122 regulates HCV by
interacting with two adjacent sites in the viral 50UTR,
immediately upstream of the IRES, and positively
regulating the viral replication cycle (3,7).
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The mechanism by which miR-122 regulates HCV is not
fully understood. miR-122 does not directly affect HCV
RNA synthesis in cells or in isolated replication complexes
(8,9). Previous work from our group and others has shown
that miR-122 binding to the HCV 50UTR stimulates HCV
IRES-driven translation (10–13). However, this minor
effect is not sufﬁcient to account for the major role
miR-122 plays in the HCV replication cycle, as miR-122
binding site mutation leads to a more severe replication
defect than IRES mutations that repress translation to a
similar extent (14). miR-122 binding was recently shown
to stabilize HCV RNA by protection from degradation by
the 50-30 exonuclease Xrn1, and it was proposed that
previous observations of activation of translation by
miR-122 could instead be explained by RNA stabilization
(15). However, protection from degradation is also insuf-
ﬁcient to explain the essential role for miR-122 in HCV
replication, as HCV RNA with mutated miR-122 binding
sites does not replicate even when Xrn1 is depleted (15).
Moreover, miR-122 with mutations that abolish regula-
tion of HCV replication can still protect HCV RNA
from degradation by Xrn1 (16), and mutation of miR-
122 binding sites does not affect Xrn1 binding to the
HCV 50UTR (13). Instead, it appears that miR-122 must
promote another stage of the HCV replication cycle, in
addition to translation and/or RNA stability, by an as
yet undetermined mechanism.
miRNAs bind to 30UTR sites and mediate their repres-
sive function in association with a complex of proteins
known as the miRNA-induced silencing complex
(miRISC), which has essential Argonaute (Ago1–4 in
mammals) and GW182 (TNRC6A-C in mammals) com-
ponents (6). The Argonaute proteins are required for miR-
122 to regulate HCV (11,12), but it is not yet known
whether additional miRISC proteins or cofactors are ne-
cessary. Interestingly, processing (P) bodies are associated
with both HCV replication and miRNA function (17,18),
raising the possibility that P bodies may be involved in
miR-122–mediated regulation of HCV. P bodies are cyto-
plasmic foci where translationally repressed mRNAs
accumulate and are degraded (19). P bodies may also
function as sites of mRNA storage before a return to
active translation (18), although the extent to which this
occurs has recently been called into question (20).
miRNAs, miRNA-repressed mRNAs and protein compo-
nents of the miRNA repression machinery associate with
P bodies, suggesting that these foci may be important for
miRNA function (18,21). P body proteins are implicated
in the replication of several RNA viruses, including brome
mosaic virus, West Nile virus, poliovirus and HCV (17,22–
24). The P body proteins Rck/p54 (DDX6), PatL1 and
LSm1 all contribute to HCV replication (17,25), while
Xrn1 represses replication in one study (15) but shows
no effect in another (17). HCV replication leads to
relocalization of Rck/p54, PatL1, LSm1 and Xrn1, but
not Dcp2, from P bodies to lipid droplets, where they
colocalize with the HCV Core protein (26–28). This
suggests that these proteins are recruited from the P
bodies to sites of HCV replication.
As miR-122 is present in P bodies (18), we considered
the possibility that regulation of HCV by miR-122 and P
body proteins might involve a common mechanism. While
Rck/p54 regulation of HCV is independent of miR-122
(25,29), and miR-122 may protect HCV RNA from deg-
radation by Xrn1 (15), the interplay between other P body
components and miR-122 in HCV regulation has not been
examined. We chose to focus on the role of LSm1 in miR-
122–mediated regulation of HCV. In eukaryotes, LSm
proteins form two highly conserved heteroheptameric
ring structures: the LSm2–8 complex, involved in
nuclear RNA processing, and the LSm1–7 complex,
which is located in P bodies (30,31). In yeast, the LSm1–
7 complex associates with deadenylated RNA and several
RNA decay factors including Pat1, protecting mRNAs
from 30 end trimming but promoting decapping and sub-
sequent 50-30 RNA degradation (30,32,33). Puriﬁed
LSm1–7-Pat1 binds directly to mRNA near the 30 end,
with higher afﬁnity for oligoadenylated RNA (34).
Intriguingly, LSm proteins are homologous to the bacter-
ial Hfq protein, which has similar functions in mRNA
decay and bacteriophage Qb replication. Hfq also acts
as a chaperone to mediate regulation of gene expression
by small RNAs (35), raising the possibility that LSm
proteins may have similar roles in small RNA activity in
eukaryotes.
In this study, we assess the role for LSm1 in miR-122–
mediated regulation of HCV. We demonstrate that LSm1
contributes to miR-122–mediated activation of HCV
IRES-driven translation in both luciferase reporters and
infectious bicistronic HCV. LSm1 depletion does not
affect miR-122–mediated repression via 30UTR sites,
indicating a specialized role for this protein in regulating
miR-122 activity at the HCV 50UTR. We show that LSm1
depletion does not affect the association between miR-
122-RISC and HCV RNA, implying that it functions to
regulate miR-122 activity subsequent to target binding.
Finally, we ﬁnd that LSm1 is not required for miR-122
to regulate HCV replication, suggesting that miR-122–
mediated regulation of HCV translation and replication
are distinct processes with different host factor
requirements.
Taken together, we have identiﬁed LSm1 as a protein
that contributes speciﬁcally to miR-122–mediated stimu-
lation of translation from the HCV IRES, but not to other
repressive functions of miR-122 or to the role of the
miRNA in HCV replication. Our results provide new
insight into the interplay between miRNAs, P bodies
and viral replication with potential relevance to future
antiviral drug development.
MATERIALS AND METHODS
Plasmids, in vitro transcription and RNA oligonucleotides
The plasmids pLUC122si, pLUC122x2 and wild-type and
mutant forms of p50LUC30 have been described previously
(3,11,36). pH77E1/p7 was a kind gift of Stanley Lemon
(37). pH77E1/p7-AAG was generated by replacing the
wild-type NS5B coding sequence with a GDD-AAG
active site mutant from a full-length H77 clone, also a
gift of Stanley Lemon (38). The double miR-122 binding
site mutant pH77E1/p7-S1+2:p3+4 was described
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previously (36). Two plasmids encoding infectious HCV
RNAs, pBi-Gluc-H77C(1a)/JFH and pFL-J6/JFH1, were
kind gifts of Charles Rice (39). In vitro transcription was
carried out using the T7 Megascript kit (Ambion) accord-
ing to the manufacturer’s instructions with EcoRI-
linearized p50LUC30 or XbaI-linearized pH77E1/p7,
pBi-Gluc-H77C(1a)/JFH1 or pFL-J6/JFH1 as templates.
The capped polyadenylated Renilla luciferase transfection
control RNA was synthesized from a linearized
pSV40-RL (Promega) template using the mMessage
mMachine kit (Ambion) and polyadenylated using the
Poly(A) tailing kit (Ambion). miRNA duplexes and
20-O-methylated oligonucleotides have been described pre-
viously (36). Synthetic pre-miR-122 had the sequence 50-U
GGAGUGUGACAAUGGUGUUUGUGUCUAAAC
UAUCAAACGCCAUUAUCACACUAAAUA-30 and
was purchased from Dharmacon.
Cell culture and transfection
Huh7 and Huh7.5 cells were cultured as previously
described (11). siRNAs are shown in Supplementary
Table S1 and were delivered into cells at 20 nM ﬁnal con-
centration using Lipofectamine RNAiMax (Invitrogen).
Cells were cultured for 48 h before RNA or DNA trans-
fection. For luciferase experiments, cells were transfected
with 0.2mg of 50LUC30 RNA (or mutant variants) with
0.01 mg capped polyadenylated Renilla luciferase RNA,
or 0.5mg of ﬁreﬂy luciferase plasmid DNA with 0.05mg
of pSV40-RL. Twenty nanomolar randomized or miR-
122–speciﬁc 20O-methylated oligonucleotide, miR122wt
duplex or miR-122p3+4 mutant duplex was also
included in the transfections, which were performed
using Lipofectamine 2000 (Invitrogen) as in (11). Cells
were harvested at 6 h after transfection for RNA or 24 h
for DNA transfections. Cells cultured in 24-well plates
were harvested in Passive Lysis Buffer (Promega) and
luciferase activity measured with the Dual luciferase
assay system (Promega) using a Glomax luminometer
(Promega). To quantify luciferase RNA, cells were
cultured in six-well plates and TRI reagent extraction
and quantitative reverse transcriptase-polymerase chain
reaction (qPCR) carried out as described below.
Electroporation was used to introduce wild-type or
mutant H77E1/p7, Bi-Gluc-H77C(1a)/JFH1 or FL-J6/
JFH1 RNA into Huh 7 or Huh7.5 cells, and to transfect
Huh7 cells with 50LUC30 RNA for immunoprecipitation
experiments. Electroporation was carried out using the
Neon system (Invitrogen) according to the manufacturer’s
instructions. Where included, siRNA or 20-O-methylated
oligonucleotide treatment was for 48 h before electropor-
ation. For HCV replication experiments, two siRNA
transfections were conducted at 72 and 24 h before elec-
troporation to ensure that knockdown was maintained in
cells harvested at 24 h after electroporation. Cells (4 105)
were resuspended in 10 ml of buffer R and mixed with 1 mg
of wild-type or mutant H77E1/p7, Bi-Gluc-H77C(1a)/
JFH1, FL-J6/JFH1 or 50LUC30 RNA, and 20 pmoles
122-20Ome or pre-miR-122 where included, before electro-
poration with a single pulse at 1300 V for 30ms. For
immunoprecipitation experiments, three electroporations
were pooled and plated on a 10-cm plate. Cells
electroporated with HCV RNA were plated in six-well
plates and total RNA extracted at 6 and 24 h after elec-
troporation using TRI reagent. A fraction of cells
electroporated with Bi-Gluc-H77C(1a)/JFH1 RNA were
plated in 24-well plates for luciferase assays. Ten micro-
liters of cell supernatant from triplicate wells was har-
vested at 1, 2, 3, 4, 6 and 24 h time points in luciferase
lysis buffer (NEB), and assayed with Gaussia luciferase
assay reagent (NEB).
Immunoprecipitation
Immunoprecipitation of Argonaute complexes was per-
formed on electroporated cells cultured in 10-cm plates
as described in (40), except that the monoclonal
antibody 11A9 (Sigma SAB4200085) was used to
immunoprecipitate Ago2. RNA was isolated from 10%
of the input cell lysate, the Ago2 immunoprecipitate and
a normal rat IgG control immunoprecipitate.
RNA isolation, northern blotting and qPCR
RNA was extracted using TRI reagent (Sigma) according
to the manufacturer’s protocol. Northern blot analysis of
HCV and g-actin RNA was carried out as described pre-
viously (36). qPCR was performed using GoTaq qPCR
Master Mix (Promega), following reverse transcription
using Superscript III and random primers, as described
in (11). qPCR primer sequences are shown in
Supplementary Table S2. The primer pair HCV qF and
HCV qR bind to the HCV 50UTR and were used to
amplify both H77E1/p7 and 50LUC30 RNA. JFH1 qF
and JFH1 qR primers were used to amplify Bi-Gluc-
H77C(1a)/JFH1 and FL-J6/JFH1 RNA. Primer speciﬁ-
city was conﬁrmed by agarose gel electrophoresis of
PCR products and dissociation curves. qPCR to detect
miR-122 and U6 small nuclear RNA (snRNA) was
carried out using speciﬁc miRNA Taqman assay kits
(Applied Biosystems) according to the manufacturer’s
protocol. qPCR was carried out using a Stratagene
Mx3005P machine, and data were analyzed by the 2-
Ct method relative to the actin mRNA or U6 control
for total RNA experiments, or ﬁtted to a standard curve
of in vitro transcribed 50LUC30 or H77E1/p7 RNA using
the MxPro software for immunoprecipitation
experiments.
Western blotting
Protein samples were obtained by resuspension of cell
pellets in 1 sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) loading dye, and
separated by electrophoresis on 15% SDS-PAGE gels
before semidry transfer to polyvinylidene diﬂuoride
(PVDF) membrane. LSm1 was detected using the
antibody GW22100F (Sigma) and b-tubulin using the
antibody ab6046 (Abcam).
Statistical analysis
All data represent averages of at least three independent
biological replicates, with error bars representing standard
Nucleic Acids Research, 2014, Vol. 42, No. 2 1259
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deviation. Statistical analysis was carried out by two-tailed
Student’s t-test for unpaired samples of equal variance.
*P< 0.05, **P< 0.005, ***P< 0.0005.
RESULTS
LSm1 contributes to miR-122-dependent stimulation of
translation from the HCV IRES
miR-122 and LSm1 both contribute to HCV replication,
at least in part by stimulating HCV translation (11,17),
and both are localized to P bodies (18). This led us to
investigate the possibility that these host factors might
cooperate to regulate HCV.
We ﬁrst established that we could effectively deplete
LSm1 in Huh7 cells by siRNA transfection (Figure 1A).
This led to a 40–50% decrease in HCV RNA in cells
electroporated with the replication-competent genotype
1a H77E1/p7 RNA (37) (Supplementary Figure S1B
and C), conﬁrming that LSm1 contributes to the accumu-
lation of HCV RNA (17,28). We tested the effects of
LSm1 depletion on HCV RNA stability by electropor-
ation of H77E1/p7 RNA with either the active site of
the NS5B polymerase (H77-AAG) or the miR-122 binding
sites mutated (H77-S1+2:p3+4) (36); both mutations
abolish HCV replication. Total RNA was harvested 6 h
after electroporation. The level of both HCV RNAs was
unaffected by LSm1 depletion (Supplementary Figure
S1D and E), showing that LSm1 regulates HCV replica-
tion without affecting viral RNA stability.
Next, we examined the role for LSm1 in miR-122–
mediated regulation of HCV translation by transfection
of in vitro transcribed reporter RNA in which the ﬁreﬂy
luciferase coding region is ﬂanked by the HCV 50 and 30
UTRs (50LUC30) (Figure 1B). We have previously
demonstrated that translation of this RNA is stimulated
by miR-122 (11). Following siRNA-mediated depletion
of LSm1 in Huh7 cells, 50LUC30 reporter RNA was de-
livered by lipofection with or without sequestration or
overexpression of miR-122. Fireﬂy luciferase activity was
determined at 6 h after transfection relative to a Renilla
luciferase transfection control (Figure 1C). In cells
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Figure 1. LSm1 contributes to miR-122 activation of HCV IRES-driven translation. (A) Western blot showing effective depletion of LSm1 by
siRNA transfection in Huh7 cells. LSm1 level relative to b-tubulin is quantiﬁed below the image. (B) Schematic diagram of the 50LUC30 reporter
RNA. The miR-122 seed matches in the HCV 50UTR are mutated at positions 3 and 4 in 50p3+4A+BLUC30 RNA. (C) Following LSm1 depletion,
Huh7 cells were transfected with 50LUC30 RNA and a capped polyadenylated Renilla luciferase transfection control, in combination with a
randomized control 20O-methylated oligonucleotide (Rand-20Ome), a 20O-methylated oligonucleotide that sequesters miR-122 (122-20Ome), a wild-
type miR-122 duplex (miR122wt) or a control duplex with two mutations in the miR-122 seed to abolish target binding (miR122p3+4). LSm1
depletion signiﬁcantly reduced ﬁreﬂy/Renilla luciferase activity in the presence of endogenous miR-122 (Rand-20Ome, miR122p3+4) or following
miR-122 overexpression (miR122wt), but did not signiﬁcantly affect luciferase production when miR-122 was inhibited (122-20Ome). (D) As (C),
except that 50p3+4A+BLUC30 RNA was used in place of 50LUC30 RNA. The RNA was delivered into cells with the miR122wt duplex, which does
not bind to the mutant target sites, or miR122p3+4, which binds and activates translation. Basal luciferase activity in the presence of miR122wt
decreased when LSm1 was depleted, but activation by miR122p3+4 decreased further. All data are the mean of at least three independent experi-
ments, +SD. *P< 0.05, ***P< 0.0005.
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containing a randomized control 20-O-methylated oligo-
nucleotide (Rand-20Ome) such that endogenous miR-122
function is unaffected, LSm1 depletion led to a 45% re-
duction in luciferase activity. RNA stability was un-
affected (Supplementary Figure S2A), indicating that
LSm1 contributes to translation of this reporter RNA.
When an antisense oligonucleotide to inhibit miR-122
was introduced into cells (122-20Ome), LSm1 depletion
resulted in only a 20% decrease in luciferase activity,
which was not statistically signiﬁcant (Figure 1C). When
miR-122 was overexpressed (miR122 wt), reporter trans-
lation was reduced by 46% when LSm1 was knocked
down, similar to the inhibition in the presence of endogen-
ous miR-122. A mutant miR-122 control duplex
(miR122p3+4) behaved similarly to the Rand-20Ome
control (Figure 1C). LSm1 depletion therefore leads to a
greater inhibition of HCV IRES-driven translation in cells
that contain endogenous (Rand-20Ome, miR122p3+4) or
overexpressed miR-122 (miR122wt) than in cells in which
miR-122 is sequestered (122-20Ome). We conﬁrmed that
luciferase RNA levels were unaffected by miR-122 deple-
tion or overexpression, as shown previously (11), and did
not change when LSm1 was depleted (Supplementary
Figure S2A). As measurement of RNA stability following
lipofection can give inaccurate results (41), we also
determined the level of 50LUC30 reporter RNA following
electroporation, and conﬁrmed that it is unaffected by
miR-122 inhibition or LSm1 depletion (Supplementary
Figure S2B). We observed a similar role for LSm1 in
miR-122–mediated translation stimulation of a reporter
RNA in which the HCV 30UTR is replaced by a poly(A)
tail (Supplementary Figure S3B). These results suggest
that LSm1 contributes to miR-122 regulation of transla-
tion via the HCV 50UTR.
We then carried out the same experiment in cells trans-
fected with a reporter RNA in which both miR-122 seed
matches are mutated at positions 3 and 4, preventing inter-
action with wild-type miR-122. This 50p3+4A+BLUC30
RNA is bound and activated by mutant miR122p3+4
(11). As endogenous miR-122 does not regulate this
reporter, we were able to measure basal translation in the
absence of miRNA binding, and found that LSm1 deple-
tion reduced luciferase activity by 30% (miR122wt control
transfection, Figure 1D). While this indicates that LSm1
stimulates HCV IRES-driven translation independently of
miR-122, we observed a 2-fold greater reduction in
luciferase activity on LSm1 knockdown when translation
was activated by miR122p3+4 transfection (58%,
miR122p3+4, Figure 1D). We obtained similar results
with a second mutant reporter RNA in which the miR-
122 seed matches were completely replaced with miR-21
seed matches, and a miR21/122 chimera was used to
activate translation (Supplementary Figure S3C). In con-
clusion, wild-type and mutant reporters all show a minor
(20–30%) reduction in translation on LSm1 knockdown in
the absence of miR-122 regulation, but a 2-fold increase in
translation inhibition by LSm1 depletion under conditions
of miRNA activation. This leads us to conclude that, while
LSm1 has a minor miR-122–independent effect on HCV
translation, it also contributes to stimulation of HCV
IRES-driven translation by miR-122.
Regulation of HCV IRES-driven translation by miR-122
is affected differently by different P body proteins
We also examined the effects of depletion of other com-
ponents of the LSm1–7 complex and P body proteins on
translation of the 50LUC30 reporter RNA. LSm1 or LSm2
depletion was effective (Figure 2A) and resulted in a
decrease in HCV RNA levels in Huh7 cells containing a
stable HCV replicon (38), whereas LSm3 depletion did not
affect HCV replication (Supplementary Figure S4A).
LSm2 depletion also led to similar effects to LSm1
knockdown on 50LUC30 RNA translation and its regula-
tion by miR-122, whereas LSm3 depletion had no effect
(Figure 2B). This raises the interesting possibility that
LSm1 regulates HCV translation as part of an alternative
LSm protein complex to the canonical LSm1–7 heptamer.
As PatL1 and Rck/p54 (DDX6) have similar effects to
LSm1 on HCV translation and replication (17), we tested
whether these host factors cooperate with miR-122 to
regulate HCV 50UTR-driven translation. PatL1 depletion
had similar effects to LSm1 or LSm2 knockdown in our
reporter assay (Figure 2C). In contrast, when Rck/p54 was
depleted we found that inhibition of reporter translation
was almost as strong when miR-122 was sequestered (48%
inhibition) as in the presence of endogenous miR-122
(56% inhibition) (Figure 2C). This agrees with previous
observations that Rck/p54 and miR-122 regulate HCV
independently (29), although our results cannot exclude
a small cooperative effect of the two factors on HCV
translation. Rck/p54 was previously found to stimulate
HCV translation in one study, but not another, and a
third study found the effects on translation to depend on
the passage of Huh7.5 cells used (17,25,29). In our hands,
in Huh7 cells, we ﬁnd that Rck/p54 stimulates HCV
IRES-driven translation.
LSm1 does not affect miR-122–mediated repression at
30UTR sites or cleavage at a complementary site
To assess whether LSm1 also contributes to the repressive
activity of miR-122 binding to 30UTR sites, we used a
luciferase reporter plasmid with two copies of the miR-
122 binding region from HCV inserted in the 30UTR
(pLUC122x2, Figure 3A). We have previously shown
that miR-122 effectively inhibits translation of the RNA
produced from this plasmid (36). Interestingly, we found
that basal translation and miR-122 regulation of this
30UTR reporter were unaffected by LSm1 depletion
(Figure 3B). We also examined the effect of LSm1 and
miR-122 on luciferase expression from a reporter
bearing an exactly complementary miR-122 site, such
that miR-122 directs cleavage of the reporter mRNA
(pLUC122si, Figure 3C). We found that LSm1 depletion
did not affect basal luciferase expression from this
plasmid, or the increase in ﬁreﬂy luciferase activity that
occurs when miR-122 is inhibited by 122-20Ome transfec-
tion (Figure 3D). Our results demonstrate that both
miRNA and siRNA-like repression by miR-122 are un-
affected by LSm1. Similarly, we found that depletion of
LSm2 or LSm3 did not affect miR-122 repression at
30UTR sites in either reporter (Supplementary Figure
S4B and C). These results imply that LSm proteins play
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a speciﬁc role in miR-122–mediated translation activation
via the HCV 50UTR and not in other functions of
miR-122.
LSm1 does not affect miR-122–RISC recruitment to the
HCV 50UTR
Our subsequent investigation focused speciﬁcally on the
interplay between LSm1 and miR-122 in regulation of
HCV. We found that miR-122 expression was unaffected
by LSm1 depletion (Figure 4A). Both our group and
others have shown that the Argonaute (Ago) proteins
function in miR-122–mediated regulation of HCV
(11,12). Using a monoclonal antibody speciﬁc to Ago2,
we were able to coimmunoprecipitate 50LUC30 RNA
from Huh7 cells 6 h after electroporation. Pretreatment
with an antisense oligonucleotide to sequester miR-122
reduced the amount of 50LUC30 RNA in the Ago2
immunoprecipitate, indicating that the interaction is
mediated through miR-122–RISC recruitment to the
RNA (122-20Ome, Figure 4B). We observed no enrich-
ment of 50LUC30 RNA with mutated miR-122 binding
sites in the Ago2 immunoprecipitate (data not shown),
conﬁrming the speciﬁcity of this interaction.
We then carried out Ago2 immunoprecipitation in Huh7
cells electroporated with 50LUC30 RNA following siRNA-
mediated depletion of LSm1. Of note, the enrichment of
50LUC30 RNA in Ago2 immunoprecipitates is reduced in
both control and LSm1 siRNA-transfected cells compared
to cells that do not contain siRNA (Figure 4B and C). This
is likely to be due to competition between transfected siRNA
and endogenous miRNA for RISC association. We found
that the association of Ago2 with 50LUC30 RNA was un-
affected by LSm1 knockdown compared with control
siRNA treatment (Figure 4C), demonstrating that LSm1 is
not required for miR-122–RISC recruitment to 50LUC30
RNA. Our results imply that LSm1 regulates miR-122 acti-
vation of HCV IRES-driven translation after the miRNA
binds. We also carried out this experiment in Huh7 cells 6 h
after electroporation with replication-competent H77E1/
p7 RNA and observed no effect of LSm1 depletion on the
association of Ago2 with HCV RNA (Figure 4D). Together,
these results indicate that LSm1 does not affect the binding
of miR-122–loaded RISC to the HCV 50UTR.
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Figure 2. Different P body proteins make different contributions to miR-122–mediated activation of HCV IRES-driven translation. (A) qPCR showing
effective depletion of LSm2, LSm3, PatL1 and Rck/p54 by transfection of the respective siRNAs. Levels of each mRNA are shown relative to actin
mRNA. (B) Huh7 cells treated with siRNAs to deplete LSm2 or 3 were transfected with 50LUC30 RNA and Rand-20Ome or 122-20Ome oligonucleotides,
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siRNA+Rand-20Ome. (C) As (B), except that Huh7 cells were treated with siRNAs to deplete PatL1 or Rck/p54. PatL1 depletion strongly reduced
luciferase activity in the presence of endogenous (Rand-20Ome, miR122p3+4) or overexpressed (miR122wt) miR-122, with less effect when miR-122 was
inhibited (122-20Ome). Rck/p54 knockdown repressed 50LUC30 translation to a similar extent irrespective of whether miR-122 was inhibited or
overexpressed. All data are an average of at least three independent experiments, +SD. *P< 0.05, **P< 0.005, ***P< 0.0005.
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LSm1 is not required for miR-122 to regulate HCV
replication
Although miR-122 binding to the HCV 50UTR stimulates
HCV IRES-driven translation and/or increases RNA sta-
bility, this effect is not sufﬁcient to explain its major role in
HCV replication, implying that other stages of the HCV
life cycle are also regulated (14,15). We tested whether
LSm1 and miR-122 cooperate to regulate HCV replication
by electroporating Huh7 cells with H77E1/p7 RNA
(Figure 5A) and plating for 24 h before LSm1 or control
siRNA transfection. The 122-20Ome oligonucleotide or
pre-miR-122 was included in the transfection to assess
the effects of miR-122 sequestration or overexpression.
By northern blotting and qPCR, we observed that LSm1
reduced HCV replication but still allowed regulation by
miR-122 (Figure 5B and C). The relative decrease in HCV
RNA levels on miR-122 inhibition was slightly, although
not signiﬁcantly, greater in LSm1-depleted (53% reduc-
tion) than control siRNA-treated (41% reduction) cells
(122-20Ome, Figure 5D). Supplementation with exogenous
pre-miR-122 increased HCV RNA levels in LSm1-
depleted cells to an even greater extent than in control
cells (Figure 5D), such that overexpressed miR-122
overcame the inhibition of HCV replication on LSm1
knockdown (Figure 5C). Together, these results indicate
that LSm1 is not required for endogenous or
overexpressed miR-122 to regulate HCV replication, in
contrast to its effects on translation.
As these experiments were carried out in cells in which
HCV replication was established, we also examined
whether LSm1 and miR-122 independently regulate early
stages of HCV replication. Huh7 cells were treated with
control or LSm1 siRNAs for 72 h before electroporation
of H77E1/p7 RNA, with or without synthetic pre-miR-
122. Total RNA was harvested at 24 h after electropor-
ation, and analyzed by northern blotting (Figure 5E) and
qPCR (Figure 5F). Co-electroporation of pre-miR-122
increased HCV RNA levels irrespective of whether
LSm1 was knocked down, but did not overcome the
effects of LSm1 depletion. The pre-miR-122–dependent
increase in HCV RNA was slightly lower in LSm1
siRNA (2.4-fold) than control siRNA-transfected cells
(2.7-fold) but was not signiﬁcantly different.
LSm1 contributes to activation of infectious HCV
translation by miR-122
Finally, we examined the effects of LSm1 and miR-122 on
translation and replication of infectious HCV RNA.
Surprisingly, LSm1 depletion did not signiﬁcantly affect
HCV replication when monocistronic FL-J6/JFH1 RNA
was introduced into theHuh7.5 cells that are generally used
for infectious virus work (Supplementary Figure S5B),
despite similar efﬁciency of knockdown to Huh7 cells
(Supplementary Figure S5C). We therefore carried out
these experiments in Huh7 cells. Cells were depleted of
LSm1 before electroporation with FL-J6/JFH1 RNA
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Figure 3. LSm1 does not affect miR-122–mediated repression via 30UTR sites or RNA cleavage at a perfectly complementary site. (A) The
pLUC122x2 plasmid, containing two copies of the miR-122 binding region from HCV in the ﬁreﬂy luciferase 30UTR. (B) Huh7 cells treated
with control or LSm1 siRNA were transfected with pLUC122x2 together with Rand-20Ome or 122-20Ome oligonucleotides, or miR122wt or
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(Figure 6A) (39). LSm1 knockdown did not affect HCV
RNA levels at 6 h post electroporation (Figure 6B),
but led to a 53% decrease at 24 h. Co-electroporation of
122-20Ome to sequester miR-122 strongly reduced HCV
replication at 24 h; under these conditions, there was no
further effect of LSm1 depletion, but as replication was
almost abolished we cannot conclude whether endogenous
miR-122 and LSm1 cooperate to regulate FL-J6/JFH1 rep-
lication. Overexpression of miR-122 stimulated FL-J6/
JFH1 replication in both control and LSm1 knockdown
cells at 24 h, and reversed the inhibitory effect of LSm1
depletion (pre-miR-122, Figure 6C), in agreement with
our observations with H77E1/p7 RNA (Figure 5C).
To examine the effects of miR-122 and LSm1 on infec-
tious HCV translation, we used a bicistronic infectious
HCV RNA in which the JFH1 (genotype 2a) 50UTR
drives translation of secreted Gaussia luciferase (Gluc),
and translation of an H77-JFH1 fusion polyprotein is
under the control of the EMCV IRES (Figure 6D).
Following knockdown of LSm1 in Huh7 cells, this
Bi-Gluc-H77c(1a)/JFH1 RNA was introduced by elec-
troporation with or without miR-122 inhibition or
overexpression. HCV RNA levels were unchanged by
miR-122 inhibition or LSm1 depletion at 6 h after electro-
poration (Supplementary Figure S6), indicating that rep-
lication had not occurred by this time point and that Gluc
was produced by translation of input RNA. LSm1 deple-
tion reduced translation by 25% relative to control
siRNA-treated cells at 2 h after electroporation, and by
40% at 3–6 h (Figure 6E). Sequestration of miR-122
by 122-20Ome led to a 50–70% decrease in translation
over the time course. There was no signiﬁcant difference
in the translation proﬁle of 122-20Ome-treated cells with
or without LSm1 depletion (Figure 6E), supporting our
conclusion that miR-122 and LSm1 cooperate to regulate
HCV translation. HCV RNA levels in Huh7 cells
electroporated with Bi-Gluc-H77c(1a)/JFH1 RNA at
24 h after electroporation were not signiﬁcantly affected
by LSm1 depletion and only slightly decreased by miR-
122 sequestration (Figure 6F). This is likely to be due to
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Figure 4. LSm1 does not affect miR-122-RISC association with the HCV 50UTR. (A) miR-122 levels determined by qPCR relative to U6 snRNA in
Huh7 cells did not change signiﬁcantly following LSm1 depletion. (B) Huh7 cells were treated with an antisense oligonucleotide to sequester miR-122
(122-20Ome) or a randomized control (Rand-20Ome) for 48 h before electroporation with 50LUC3 RNA. Six hours after electroporation, cell lysates
were immunoprecipitated with an anti-Ago2 monoclonal antibody or a normal rat IgG control. Immunoprecipitated RNA levels relative to input
were determined by qPCR, and demonstrate that the association of Ago2 with 50LUC30 RNA is miR-122-dependent. (C) As (B), except that cells
were treated with an siRNA speciﬁc to LSm1, or a control nontargeting siRNA, instead of the oligonucleotides in (B). LSm1 depletion did not
signiﬁcantly affect Ago2 association with 50LUC30 RNA. (D) As (C), except that cells were electroporated with H77E1/p7 RNA instead of 50LUC30
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the low replication of this RNA in these cells
(Supplementary Figure S7A). HCV RNA levels were
increased by pre-miR-122, and this increase was reduced
by LSm1 depletion (Figure 6F), suggesting that LSm1
may contribute to induction of early replication of this
RNA by miR-122 overexpression.
DISCUSSION
In this study, we identify LSm1 as a cofactor for miR-122
to stimulate HCV IRES-driven translation (Figures 1
and 6). Our results conﬁrm previous observations that
LSm1 contributes to HCV replication and translation
(17,28), but extend this earlier work by demonstrating
that the effect on translation involves miR-122. We note
that LSm1 does make a small contribution to translation
of luciferase reporters in the absence of miR-122 binding,
but we consistently observe at least a 2-fold increase in the
response to LSm1 when miR-122 regulation occurs. We
observe no effect of either LSm1 or miR-122 on reporter
RNA stability (Supplementary Figure S2), indicating that
regulation is at the level to translation. In contrast to
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Figure 5. LSm1 is not required for endogenous or overexpressed miR-122 to regulate HCV replication. (A) Structure of H77E1/p7 RNA.
(B) Huh7 cells were electroporated with H77E1/p7 RNA, cultured for 24 h, then transfected with a control siRNA or an siRNA targeting
LSm1, with or without cotransfection of 122-20Ome or synthetic pre-miR-122. HCV and actin RNA were detected by northern blotting. (C) As
(B), except that HCV RNA levels were determined relative to actin mRNA by qPCR. miR-122 overexpression overcame inhibition of HCV
replication by LSm1 knockdown. (D) The data shown in (C) replotted relative to the no oligonucleotide control for each siRNA. (E) Following
LSm1 depletion, Huh7 cells were electroporated with H77E1/p7 RNA, with or without synthetic pre-miR-122. Total RNA was harvested at 24 h
after electroporation and analyzed by northern blotting. Pre-miR-122 overexpression increased the level of HCV RNA in both control and LSm1
siRNA-transfected cells. (F) As (E), except that HCV RNA levels were determined relative to actin mRNA by qPCR. qPCR data represent an
average of three independent experiments, +SD. *P< 0.05, ***P< 0.0005.
Nucleic Acids Research, 2014, Vol. 42, No. 2 1265
 at U
niversity of N
ottingham
 on A
pril 29, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Scheller et al (17), we ﬁnd that the HCV 30UTR is not
required for regulation of reporter translation by LSm1
and miR-122 (Supplementary Figure S3B). Differences in
experimental techniques, such as the knockdown method,
time of transfection or the precise nature of the reporter
RNA might account for this disparity, but as regulation at
the 50UTR was the main focus of this investigation, we did
not pursue this question.
We ﬁnd that LSm1 does not contribute to translation
repression mediated by miR-122 binding to 30UTR sites
or the siRNA-like activity that occurs when miR-122
encounters a perfectly complementary site (Figure 3).
While LSm1–7 and miRNA pathway components
colocalize in P bodies, it was previously shown that P
body depletion by LSm1 knockdown does not affect
miRNA or siRNA-mediated silencing (42), in agreement
with our data. The role for LSm1 in regulation of miR-
122 activity is therefore speciﬁc to activation of translation
at the HCV 50UTR, providing an intriguing ﬁrst example of
a protein factor that is not required for miRNA repressive
functions but does contribute to a speciﬁc alternative
miRNA activity. The mechanisms that allow a miRNA
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Figure 6. LSm1 contributes to miR-122–mediated regulation of infectious HCV translation. (A) Schematic diagram of the infectious FL-J6/JFH1
RNA. (B) Following treatment with an siRNA to deplete LSm1 or a nontargeting control, Huh7 cells were electroporated with FL-J6/JFH1 RNA
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to mediate the different functions of translational repres-
sion by binding to 30UTR sites or activation of translation/
viral replication by binding to 50UTR sites are unclear. Our
work provides an insight into these different mechanisms,
indicating that speciﬁc protein factors may play a role. We
previously demonstrated that the core miRISC components
Ago1–4 are required for miR-122 to stimulate translation
via the HCV 50UTR, whereas the TNRC6 proteins, which
are also essential for miRNA-mediated repression, only
play a minor role in this process (11). Together, these
results suggest that specialized miRISCs may mediate
speciﬁc miRNA functions.
We conﬁrm the published observation that LSm1 deple-
tion does not affect the level of miR-122 (28). We also
establish that Ago2 is speciﬁcally recruited to the HCV
50UTR by miR-122, in agreement with recent studies
(13,43). We ﬁnd that this miR-122–RISC recruitment is
unaffected by LSm1 knockdown (Figure 4), implying that
LSm1 regulates miR-122 activity at the HCV 50UTR sub-
sequent to target binding. These results agree with our
observation that LSm1 does not regulate miR-122 regula-
tion at 30UTR sites (Figure 3), as we would expect these
processes to be inhibited by LSm1 depletion if miR-122
levels or target binding by miR-122–RISC were affected.
Instead, LSm1 appears to be speciﬁcally involved in the
activation of HCV IRES-driven translation that occurs
following miR-122 binding. While this argues against a
chaperone function in target binding by small RNAs
similar to that of bacterial Hfq (35), LSm1 may act as a
chaperone for secondary or tertiary structural changes in
the HCV 50UTR when miR-122 is bound. Such a role was
recently proposed for LSm1, PatL1 and Dhh1 in ﬂock
house virus replication in yeast, as these proteins speciﬁc-
ally affect the generation of viral RNA3, which depends
on long-range RNA–RNA interactions in RNA1 (44).
The LSm1–7 complex binds in vitro to domain III of the
HCV IRES (17), a region that we found was important for
miR-122–mediated activation of translation (11). As miR-
122 binding causes alterations in HCV 50UTR structure
away from the miR-122 binding sites (16,45), it is possible
miR-122 and LSm1 may cooperate to restructure the
HCV IRES in a manner that stimulates translation.
In contrast to translation, we ﬁnd that inhibition of
HCV replication by miR-122 sequestration is not
affected by LSm1 depletion (Figure 5). This suggests
that regulation of HCV translation and replication by
miR-122 are different processes with different require-
ments for host factors such as LSm1. Overexpression of
miR-122 can overcome the repressive effects of LSm1
knockdown on HCV replication in this established
H77E1/p7 replication system, or at 24 h after electropor-
ation of FL-J6/JFH1 RNA (Figures 5C and 6C). miR-122
overexpression also overcomes the repression of HCV rep-
lication induced by depletion of the P body component
RCK/p54 (DDX6), which led to the conclusion that
miR-122 and Rck/p54 modulate HCV replication by in-
dependent mechanisms or possibly by redundant
pathways (25).
Importantly, we observed several differences in our
translation and replication experiments between the
effects of endogenous and overexpressed miR-122,
between the different viral RNAs and between Huh7
and Huh7.5 cells. Overexpression of miR-122 in Huh7
cells stimulates 50LUC30 reporter translation to the same
extent whether or not LSm1 is depleted (Figure 1C). In
contrast, both activation of wild-type reporter or viral
translation by endogenous miR-122, and activation of
mutant reporter RNA translation by mutant miR-122,
are more sensitive to LSm1 depletion than basal transla-
tion in the absence of miRNA regulation (Figure 1C and
D). These results suggest that LSm1 is important for miR-
122–mediated stimulation of HCV IRES-driven transla-
tion from a low, basal level but does not contribute to
further stimulation when miR-122 is increased beyond
its endogenous level.
We observed different effects of LSm1 and miR-122 on
the three different viral RNAs we tested, which might
be due to differences in replication efﬁciency. At 24h
after electroporation, FL-J6/JFH1 replication is strong
(Supplementary Figure S7A) and pre-miR-122 over-
expression overcomes the repressive effects of LSm1 deple-
tion (Figure 6C). This agrees with our observations in the
context of established H77E1/p7 replication (Figure 5C).
In contrast, H77E1/p7 RNA replication at 24h after
electroporation is only 10% of that of FL-J6/JFH1
(Supplementary Figure S7A); pre-miR-122 overexpression
stimulates replication when LSm1 is knocked down, but
does not overcome the requirement for LSm1
(Figure 5F). We observe no reduction in Bi-Gluc-
H77C(1a)/JFH1 RNA levels at 24h after electroporation
on LSm1 depletion (Figure 6F), probably because replica-
tion of this RNA is so low that HCV RNA expression is
largely a measure of RNA stability (Supplementary Figure
S7A). However, LSm1 is required for the replication that
occurs following overexpression of pre-miR-122
(Figure 6F). Together, these observations suggest that
when HCV replication is efﬁcient and is maximized by
miR-122 overexpression, it does not require LSm1. LSm1
is more important for inefﬁcient HCV replication, and
perhaps cooperates with miR-122 to contribute to the
switch from translation to early replication.
In agreement with this model, we ﬁnd that LSm1 does
not contribute to replication of FL-J6/JFH1 RNA in
Huh7.5 cells (Supplementary Figure S5B), where replica-
tion is 3-fold more efﬁcient than in Huh7 cells and miR-
122 levels are higher (Supplementary Figure S7). LSm1
knockdown is equally efﬁcient in Huh7.5 and Huh7 cells
(Supplementary Figure 5C). While other groups have
observed stronger effects of LSm1 depletion on JFH1 rep-
lication in Huh7.5 cells, our different results may be due to
differences between the JFH1-derived RNA or Huh7.5
isolates used, or to less efﬁcient LSm1 knockdown.
Translation of 50LUC30 or Bi-Gluc-H77C(1a)/JFH1
RNA is also less sensitive to LSm1 depletion in Huh7.5
cells than Huh7 (data not shown). Different Huh7 isolates
have been shown to differ in physiology and HCV infect-
ivity (46), while Rck/p54 depletion has different effects on
HCV translation in different passages of Huh7.5 cells and
in different studies (17,25,29). Together, these observa-
tions support the idea that HCV may have different sen-
sitivity to cofactors in different Huh7 or Huh7.5 cell
isolates.
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HCV infection leads to the disruption of P bodies and
relocalization of speciﬁc P body proteins to sites of viral
replication, while P body disruption by depletion of Dcp2
or TNRC6A does not affect HCV replication. Ago2 and
miR-122 also move out of P bodies and associate with
lipid droplets in HCV-infected cells (17,26,28,47).
Together, these observations suggest that both LSm1
and miR-122 regulate HCV translation and replication
outside the P bodies. It is still not clear how P body
proteins assist HCV replication, although both our data
and that of other groups suggest that at least some of this
effect occurs by stimulation of viral translation (Figures 1
and 6) (17). P body proteins including LSm1 have also
been implicated in the replication of a number of different
RNA viruses (23,48), suggesting that similar mechanisms
of regulation may be involved. The P body proteins may
contribute to the switch from translation to replication of
viral RNA, perhaps by modulating RNA structure or lo-
calization of RNA to replication complexes. As P bodies
are dynamic, it will be interesting to determine whether
viral RNA initially interacts with these regulatory proteins
within the P bodies, leading to disruption of these foci, or
associates with free pools of the proteins in the cytoplasm
and prevents P body formation.
The function of LSm1 in mRNA decapping and decay is
not yet fully understood, but several lines of evidence
indicate that it has additional functions in RNAmetabolism.
LSm1–7 binds and stabilizes RNAmolecules with 50 poly(A)
tracts, such as the orthopoxvirus mRNAs (49). LSm1 and
LSm4 are found in mRNP complexes in neuronal dendrites,
where it was proposed that these proteins function in regu-
lation of localized protein synthesis (50). We ﬁnd that only a
subset of the LSm proteins we tested affect HCV IRES-
driven translation, raising the possibility that alternative
complexes of LSm proteins may exist in cells and regulate
viral replication. In the heteroheptameric LSm1–7 ring,
LSm1 interacts directly with LSm2 but not LSm3. We
observe that LSm1 and LSm2 have similar effects on miR-
122 regulation of HCV IRES-driven translation and on
HCV replication, whereas LSm3 does not affect this
process (Figure 2 and Supplementary Figure S4).
Alternative LSm multimers can assemble in vitro (51). Our
results suggest that LSm1 may function in a complex other
than LSm1–7 to stimulate HCV IRES-driven translation in
a manner that involves miR-122.
It has been clearly shown that the minor effects of miR-
122 on HCV translation or RNA stability are not sufﬁcient
to explain the requirement for this miRNA for HCV repli-
cation (14,15,16), implying that miR-122 also regulates a
later stage of the viral replication cycle. This second regu-
lation event has proven difﬁcult to identify; miR-122 does
not affect HCV RNA synthesis either in puriﬁed replication
complexes, or by 4-thio-uridine labeling of nascent RNA
(8,9). It remains possible that miR-122 is important for
processes such as initiation of HCV replication. Our obser-
vation that LSm1 contributes to miR-122–mediated activa-
tion of HCV IRES-driven translation, but is not required
for miR-122 to regulate HCV replication, supports the hy-
pothesis that the miRNA exerts multiple effects on the
HCV replication cycle.
This work provides new insight into the mechanisms by
which both miR-122 and LSm1 regulate HCV, and forms
a basis for future research to elucidate the function of
these important host factors in more detail.
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